Xenon Pharmaceuticals (XENE) Accounts Payables (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Accounts Payables of $5.7 million for Q1 2026, down 16.48% year-over-year from $6.9 million in Q1 2025, and up 47.95% quarter-over-quarter from $3.9 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Accounts Payables (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Accounts Payables for 14 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 16.48% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (down 16.48% YoY), while the FY2025 annual figure was $3.9 million, down 88.65% from the prior year.
- Accounts Payables improved to $5.7 million in Q1 2026 per XENE's latest filing, from $3.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $36.8 million in Q3 2025 and bottomed at $3.9 million in Q4 2025.
- Historically, Accounts Payables has averaged $18.7 million across 5 years, with a median of $15.5 million in 2022.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 403.63% — and 2025, when it plunged 88.65%.
- Xenon Pharmaceuticals' Accounts Payables stood at $8.5 million in 2022, then soared by 205.9% to $26.0 million in 2023, then jumped by 31.75% to $34.2 million in 2024, then slumped by 88.65% to $3.9 million in 2025, then surged by 47.95% to $5.7 million in 2026.
- Business Quant data shows XENE's Accounts Payables at $5.7 million in Q1 2026, $3.9 million in Q4 2025, and $36.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | 43.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.67 Mn |
| Mar 31, 2026 | 5.75 Mn |
| Dec 31, 2025 | 3.89 Mn |
| Sep 30, 2025 | 36.84 Mn |
| Jun 30, 2025 | 31.59 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 34.22 Mn |
| Sep 30, 2024 | 28.31 Mn |
| Jun 30, 2024 | 29.93 Mn |
| Mar 31, 2024 | 6.43 Mn |
| Dec 31, 2023 | 25.97 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Jun 30, 2023 | 26.94 Mn |
| Mar 31, 2023 | 11.41 Mn |
| Dec 31, 2022 | 8.49 Mn |
| Sep 30, 2022 | 15.54 Mn |
| Jun 30, 2022 | 13.74 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 13.72 Mn |
| Sep 30, 2021 | 3.09 Mn |